Skip to main content
SpringerLink
Log in

VAERS reports find no new safety concerns for Bexsero

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Perez-Vilar S, et al. Safety surveillance of meningococcal group B vaccine (Bexsero(R)), Vaccine Adverse Event Reporting System, 2015-2018. Vaccine : 6 Dec 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.11.071

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

VAERS reports find no new safety concerns for Bexsero. Reactions Weekly 1887, 12 (2022). https://doi.org/10.1007/s40278-022-07677-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-07677-3

Search

Navigation